Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir vs entecavir + adefovir in chronic hepatitis B patients with YMDD mutation and suboptimal response to lamivudine + adefovir
KCT0000627Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir, entecavir, adefovir dipivoxil, lamivudine in Chronic Hepatitis B (CHB), sponsored by Gilead Sciences. Started Aug 2013; status: completed.
02
Drugs
tenofovirentecaviradefovir dipivoxillamivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on KCT0000627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000627.